Home > Boards > US OTC > Biotechs > Vivos Inc. (RDGL)

Expected catalysts in the near future or later:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
bdvest Member Profile
 
Followed By 8
Posts 751
Boards Moderated 0
Alias Born 10/11/18
160x600 placeholder
Amended Registration a Offering Under the Securities Act of 1933 (1-a/a) Edgar (US Regulatory) - 11/20/2019 4:48:11 PM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 11/14/2019 3:21:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2019 11:03:10 AM
Amended Registration a Offering Under the Securities Act of 1933 (1-a/a) Edgar (US Regulatory) - 10/8/2019 5:25:19 PM
Amended Registration a Offering Under the Securities Act of 1933 (1-a/a) Edgar (US Regulatory) - 9/9/2019 11:58:14 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 3:46:20 PM
Registration a Offering Under the Securities Act of 1933 (1-a) Edgar (US Regulatory) - 7/29/2019 11:45:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2019 1:27:29 PM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 6/24/2019 1:20:58 PM
Information Statement (definitive, Revised) (defr14c) Edgar (US Regulatory) - 5/22/2019 5:03:56 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 5/16/2019 1:48:24 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/13/2019 4:17:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/6/2019 6:05:49 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 4/29/2019 6:16:09 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/2/2019 5:14:00 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/25/2019 1:29:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/31/2019 5:22:33 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/12/2018 2:45:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/11/2018 6:12:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/6/2018 6:10:34 AM
bdvest   Sunday, 10/20/19 02:01:39 PM
Re: bdvest post# 125189
Post # of 125739 
Expected catalysts in the near future or later:
1. PR of the publication of animal treatments and the submission to FDA for human trial approval;
2. Closing of the offering, and we may see private investment replacement of equity;
3. Opening of new animal clinics of isopet treatment;
4. Good deals of partnership with renown biopharma or biotech company with decent upfront payment;
5. Licensing deals of isopet or radiogel to other countries or regions;

The important thing is getting the ticket on board, the road may be still bumpy and for sure it is heading to the north, right now it is much undervalued, but it won't be long until it is up at a higher level.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist